BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.

Source:http://linkedlifedata.com/resource/pubmed/id/19483105

Download in:

View as

General Info

PMID
19483105